These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15338193)

  • 21. In vivo disposition and in vitro metabolism of an anxiolytic compound, BMS-184111, in rats.
    Yeleswaram K; Volk KJ; Rourick R; Catt JD; Mattson RJ; McGoff KB; Knipe JO
    Res Commun Mol Pathol Pharmacol; 1995 Jul; 89(1):27-44. PubMed ID: 7582859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prodrugs of BMS-183920: metabolism and permeability considerations.
    Obermeier MT; Chong S; Dando SA; Marino AM; Ryono DE; Starrett-Arroyo A; DiDonato GC; Warrack BM; White RE; Morrison RA
    J Pharm Sci; 1996 Aug; 85(8):828-33. PubMed ID: 8863272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-clinical evidence of enhanced oral bioavailability of the P-glycoprotein substrate talinolol in combination with morin.
    Pathak SM; Udupa N
    Biopharm Drug Dispos; 2010 Mar; 31(2-3):202-14. PubMed ID: 20238375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P-glycoprotein plays a major role in the efflux of fexofenadine in the small intestine and blood-brain barrier, but only a limited role in its biliary excretion.
    Tahara H; Kusuhara H; Fuse E; Sugiyama Y
    Drug Metab Dispos; 2005 Jul; 33(7):963-8. PubMed ID: 15821041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ethanol metabolite acetaldehyde increases paracellular drug permeability in vitro and oral bioavailability in vivo.
    Fisher SJ; Swaan PW; Eddington ND
    J Pharmacol Exp Ther; 2010 Jan; 332(1):326-33. PubMed ID: 19820208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of P-glycoprotein on intestinal absorption and brain penetration of antiallergic agent bepotastine besilate.
    Ohashi R; Kamikozawa Y; Sugiura M; Fukuda H; Yabuuchi H; Tamai I
    Drug Metab Dispos; 2006 May; 34(5):793-9. PubMed ID: 16455807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of enaminones on the transport and oral bioavailability of P-glycoprotein substrate therapeutic agents.
    Salama NN; Scott KR; Eddington ND
    Int J Pharm; 2004 Apr; 273(1-2):135-47. PubMed ID: 15010138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro to in vivo comparison of the substrate characteristics of sorafenib tosylate toward P-glycoprotein.
    Gnoth MJ; Sandmann S; Engel K; Radtke M
    Drug Metab Dispos; 2010 Aug; 38(8):1341-6. PubMed ID: 20413726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo induction of hepatic p-glycoprotein by cyclosporine in the rat.
    Bai S; Liu J; Lu SK; Brunner LJ
    Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):103-14. PubMed ID: 11458978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization of in vitro Caco-2 permeability and liver microsomal half-life screens in discovering BMS-488043, a novel HIV-1 attachment inhibitor with improved pharmacokinetic properties.
    Yang Z; Zadjura LM; Marino AM; D'Arienzo CJ; Malinowski J; Gesenberg C; Lin PF; Colonno RJ; Wang T; Kadow JF; Meanwell NA; Hansel SB
    J Pharm Sci; 2010 Apr; 99(4):2135-52. PubMed ID: 19780144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple pathways are involved in the oral absorption of BMS-262084, a tryptase inhibitor, in rats: role of paracellular transport, binding to trypsin, and P-glycoprotein efflux.
    Kamath AV; Morrison RA; Harper TW; Lan SJ; Marino AM; Chong S
    J Pharm Sci; 2005 May; 94(5):1115-23. PubMed ID: 15793809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of P-glycoprotein and cytochrome P450 3a on the oral bioavailability of vinorelbine in mice.
    Press RR; Buckle T; Beijnen JH; van Tellingen O
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):819-25. PubMed ID: 16163538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral bioavailability and intestinal secretion of amitriptyline: Role of P-glycoprotein?
    Abaut AY; Chevanne F; Le Corre P
    Int J Pharm; 2007 Feb; 330(1-2):121-8. PubMed ID: 17092666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
    Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
    J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studies.
    Prueksaritanont T; Gorham LM; Ellis JD; Fernandez-Metzler C; Deluna P; Gehret JR; Strong KL; Hochman JH; Askew BC; Duggan ME; Gilbert JD; Lin JH; Vyas KP
    Drug Metab Dispos; 1996 Nov; 24(11):1263-71. PubMed ID: 8937862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marked impact of P-glycoprotein on the absorption of TAK-427 in rats.
    Takeuchi T; Nonaka M; Yoshitomi S; Higuchi T; Ebihara T; Maeshiba Y; Kawase M; Asahi S
    Biopharm Drug Dispos; 2008 Sep; 29(6):311-23. PubMed ID: 18651556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The limited intestinal absorption via paracellular pathway is responsible for the low oral bioavailability of doxorubicin.
    Kim JE; Cho HJ; Kim JS; Shim CK; Chung SJ; Oak MH; Yoon IS; Kim DD
    Xenobiotica; 2013 Jul; 43(7):579-91. PubMed ID: 23252722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies.
    Sharma P; Varma MV; Chawla HP; Panchagnula R
    Farmaco; 2005; 60(11-12):874-83. PubMed ID: 16243320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical pharmacokinetics and in vitro metabolism of BMS-605339: a novel HCV NS3 protease inhibitor.
    Jenkins S; Scola P; McPhee F; Knipe J; Gesenberg C; Sinz M; Arora V; Pilcher G; Santone K
    J Pharm Sci; 2014 Jun; 103(6):1891-902. PubMed ID: 24700293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-linear pharmacokinetics of oleanolic acid after intravenous and oral administration in rats.
    Jeong DW; Kim YH; Kim HH; Ji HY; Yoo SD; Choi WR; Lee SM; Han CK; Lee HS
    Biopharm Drug Dispos; 2007 Mar; 28(2):51-7. PubMed ID: 17163409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.